Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

8 Sökresultat.
Relevans Bedömning Nya först Gamla först

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 11 - Therapieende

- 2017-11-20 - 1 Formulär, 7 Item-grupper, 53 Dataelement, 1 Språk
Item-grupper: Administrative Documentation, Physical Examination, Laboratory Data, Diagnostic procedures, Results, Progress, Administrative Documentation
Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 11 - Therapieende (Woche 28) Toxizitäten / Unerwünschte Ereignisse / Hospitalisierungen werden im 1. Follow up dokumentiert. Das 1. Follow-up findet 3 Monate nach der letzten Chemotherapie statt.

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 8

- 2017-11-20 - 1 Formulär, 10 Item-grupper, 71 Dataelement, 1 Språk
Item-grupper: Administrative Documentation, Adverse Event, Physical Examination, Laboratory Data, Disease Progression, Diagnostic procedures, Postoperative Chemotherapy, Capecitabine, Life quality, Administrative Documentation
Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 8 - Chemotherapie-Zyklus 4 (Woche 19)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 10

- 2017-11-20 - 1 Formulär, 9 Item-grupper, 65 Dataelement, 1 Språk
Item-grupper: Administrative Documentation, Physical Examination, Laboratory Data, Disease Progression, Additive Chemotherapy, Capecitabine, Life quality, Adverse Event, Administrative Documentation
Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 10 - Chemotherapie-Zyklus 6 (Woche 25)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 9

- 2017-11-20 - 1 Formulär, 7 Item-grupper, 62 Dataelement, 1 Språk
Item-grupper: Administrative Documentation, Physical Examination, Laboratory Data, Additive Chemotherapy, Capecitabine, Adverse Event, Administrative Documentation
Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 8 - Chemotherapie-Zyklus 5 (Woche 22)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 7 - Entlassung

- 2017-11-19 - 1 Formulär, 8 Item-grupper, 58 Dataelement, 1 Språk
Item-grupper: Administrative Documentation, Hospital stay information, Physical Examination, Laboratory Data, Non-surgical Complications, Surgical Complications, Adverse Event, Administrative Documentation
Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 7 – Entlassung

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 4

- 2017-11-16 - 1 Formulär, 8 Item-grupper, 57 Dataelement, 1 Språk
Item-grupper: Administrative Documentation, Physical Examination, Laboratory Data, Diagnostic procedures, Results, Disease Progression, Adverse Event, Administrative Documentation
Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 4 – Ende Chemotherapie-Zyklus 3 (Woche 9)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 3

- 2017-11-16 - 1 Formulär, 8 Item-grupper, 64 Dataelement, 1 Språk
Item-grupper: Administrative Documentation, Physical Examination, Laboratory Data, Disease Progression, Preoperative Chemotherapy, Capecitabine, Adverse Event, Administrative Documentation
Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 3 – Chemotherapie-Zyklus 3 (Woche 6)

Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis (GASTRIPEC) - Visit 2

- 2017-11-16 - 1 Formulär, 8 Item-grupper, 64 Dataelement, 1 Språk
Item-grupper: Administrative Documentation, Physical Examination, Laboratory Data, Disease Progression, Preoperative Chemotherapy, Capecitabine, Adverse Event, Administrative Documentation
Prospective Multicenter Phase III Trial Using CRS With / Without HIPEC After Preoperative Chemotherapy in Patients With Peritoneal Carcinomatosis of Gastric Cancer Incl. Adenocarcinoma of the Esophagogastric Junction NCT-Identifier: NCT02158988 Source: Prof. Dr. med. Beate Rau, MBA Charité Universitätsmedizin Berlin Visit 2 – Chemotherapie-Zyklus 2 (Woche 3)

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial